Bob Carpenter, chairman of the Olaris Board of Directors, is a leader and pioneer in the healthcare and biotechnology industries. He has founded and led several companies, including VacTex, Inc. (acquired by Aquila Biopharmaceuticals) and GelTex Pharmaceuticals, and Integrated Genetics (since merged with Genzyme). He has held EVP, CEO, chairman, and Board of Director roles at Genzyme’s IG laboratories, Good Start Genetics, Lysosomal Therapeutics, Hydra Biosciences,  Immuneering Inc, and Moderna.